The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma

Cancer Biology and Therapy

Volumn 15, Issue 10, 2014, Pages 1431-1437

  Franklin, Renty B ^a,b   Zou, Jing ^a,b   Costello, Leslie C ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Ductal adenocarcinoma; Pancreatic cancer; PanIN; RREB1; Zinc; Zinc transporter; ZIP3

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RREB1; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP3 ZINC TRANSPORTER; CATION TRANSPORT PROTEIN; DNA BINDING PROTEIN; RREB1 PROTEIN, HUMAN; SLC39A3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL LEVEL; CELL PROLIFERATION; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; ADENOCARCINOMA; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; HUMANS; PANCREATIC NEOPLASMS; TRANSCRIPTION FACTORS; ZINC;

EID: 84908404331     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.29927     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29; PMID: 22237781; http://dx.doi.org/10.3322/caac.20138
2. Franklin RB, Costello LC. The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem 2009; 106: 750-7; PMID: 19160419; http://dx.doi.org/10.1002/jcb.22049
3. Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 2007; 463: 211-7; PMID: 17400177; http://dx.doi.org/10.1016/j.abb.2007.02.033
4. Costello LC, Franklin RB. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert Rev Anticancer Ther 2012; 12: 121-8; PMID: 22149438; http://dx.doi.org/10.1586/era.11.190
5. Costello LC, Franklin RB. A review of the current status and concept of the emerging implications of zinc and zinc transporters in the development of pancreatic cancer. Pancreat Disord Ther 2013; (Suppl 4); PMID: 24195024
6. Costello LC, Levy BA, Desouki MM, Zou J, Bagasra O, Johnson LA, Hanna N, Franklin RB. Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma. Cancer Biol Ther 2011; 12: 297-303; PMID: 21613827; http://dx.doi.org/10.4161/cbt.12.4.16356
7. Costello LC, Zou J, Desouki MM, Franklin RB. Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma. J Gastrointest Cancer 2012; 43: 570-8; PMID: 22427155; http://dx.doi.org/10.1007/s12029-012-9378-1
8. Mao X, Schimmer AD. The toxicology of Clioquinol. Toxicol Lett 2008; 182: 1-6; PMID: 18812216; http://dx.doi.org/10.1016/j.toxlet.2008.08.015
9. Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther 2012; 18: 41-6; PMID: 21199452; http://dx.doi.org/10.1111/j.1755-5949.2010.00231.x
10. Donadelli M, Dalla Pozza E, Scupoli MT, Costanzo C, Scarpa A, Palmieri M. Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis. Biochim Biophys Acta 2009; 1793: 273-80; PMID: 18951928; http://dx.doi.org/10.1016/j.bbamcr.2008.09.010
11. Jayaraman AK, Jayaraman S. Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells. J Nutr Biochem 2011; 22: 79-88; PMID: 20392624; http://dx.doi.org/10.1016/j.jnutbio.2009.12.001
12. Donadelli M, Dalla Pozza E, Costanzo C, Scupoli MT, Scarpa A, Palmieri M. Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. J Cell Biochem 2008; 104: 202-12; PMID: 17979179; http://dx.doi.org/10.1002/jcb.21613
13. Li M, Zhang Y, Liu Z, Bharadwaj U, Wang H, Wang X, Zhang S, Liuzzi JP, Chang SM, Cousins RJ, et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A 2007; 104: 18636-41; PMID: 18003899; http://dx.doi.org/10.1073/pnas.0709307104
14. Li M, Zhang Y, Bharadwaj U, Zhai Q J, Ahern CH, Fisher WE, Brunicardi FC, Logsdon CD, Chen C, Yao Q. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res 2009; 15: 5993-6001; PMID: 19755388; http://dx.doi.org/10.1158/1078-0432.CCR-09-0557
15. Yang J, Zhang Y, Cui X, Yao W, Yu X, Cen P, Hodges SE, Fisher WE, Brunicardi FC, Chen C, et al. Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer. Curr Mol Med 2013; 13: 401-9; PMID: 23331012
16. Zhang Y, Yang J, Cui X, Chen Y, Zhu VF, Hagan JP, Wang H, Yu X, Hodges SE, Fang J, et al. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med 2013; 5: 1322-34; PMID: 23857777; http://dx.doi.org/10.1002/emmm.201302507
17. Cui X, Zhang Y, Yang J, Sun X, Hagan JP, Guha S, Li M. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Cell Cycle 2014; 13: 1180-6; PMID: 24553114; http://dx.doi.org/10.4161/cc.28111
18. Costello LC, Fenselau CC, Franklin RB. Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells. J Inorg Biochem 2011; 105: 589-99; PMID: 21440525; http://dx.doi.org/10.1016/j.jinorgbio.2011.02.002
19. Jansen RJ, Robinson DP, Frank RD, Anderson KE, Bamlet WR, Oberg AL, Rabe KG, Olson JE, Sinha R, Petersen GM, et al. Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study. Int J Cancer 2014; 134: 1935-46; PMID: 24590454; http://dx.doi.org/10.1002/ijc.28525
20. Farzin L, Moassesi ME, Sajadi F, Faghih MAA Evaluation of trace elements in pancreatic cancer patients in Iran. Middle East J Cancer 2013; 4: 79-86
21. Fabris C, Farini R, Del Favero G, Gurrieri G, Piccoli A, Sturniolo GC, Panucci A, Naccarato R. Copper. zinc and copper/zinc ratio in chronic pancreatitis and pancreatic cancer. Clin Biochem 1985; 18: 373-5; PMID: 4092355; http://dx.doi.org/10.1016/S0009-9120(85)80078-3
22. Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, Diamond L, Mabry M, Ball DW, Baylin SB, Nelkin BD. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 1996; 16: 5335-45; PMID: 8816445
23. Liu H, Hew HC, Lu ZG, Yamaguchi T, Miki Y, Yoshida K. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter. Biochem J 2009; 422: 543-51; PMID: 19558368; http://dx.doi.org/10.1042/BJ20090342
24. Jiang W, Sequeira JM, Nakayama Y, Lai SC, Quadros EV. Characterization of the promoter region of TCblR/CD320 gene, the receptor for cellular uptake of transcobalamin-bound cobalamin. Gene 2010; 466: 49-55; PMID: 20627121; http://dx.doi.org/10.1016/j.gene.2010.07.004
25. Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, Kim J, Chung LW, Adam RM, Ray SK, Leiter AB, et al. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol 2007; 21: 2056-70; PMID: 17550981; http://dx.doi.org/10.1210/me.2006-0503
26. Flajollet S, Poras I, Carosella ED, Moreau P. RREB-1 is a transcriptional repressor of HLA-G. J Immunol 2009; 183: 6948-59; PMID: 19890057; http://dx.doi.org/10.4049/jimmunol.0902053
27. Kent OA, Fox-Talbot K, Halushka MK. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 2013; 32: 2576-85; PMID: 22751122; http://dx.doi.org/10.1038/onc.2012.266
28. Milon BC, Agyapong A, Bautista R, Costello LC, Franklin RB. Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells. Prostate 2010; 70: 288-96; PMID: 19802870
29. Oxford G, Smith SC, Hampton G, Theodorescu D. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector. Oncogene 2007; 26: 7143-52; PMID: 17496927; http://dx.doi.org/10.1038/sj.onc.1210521
30. Scarlett CJ, Salisbury EL, Biankin AV, Kench J. Precursor lesions in pancreatic cancer: morphological and molecular pathology. Pathology 2011; 43: 183-200; PMID: 21436628; http://dx.doi.org/10.1097/PAT.0b013e3283445e3a
31. th, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 2010; 10: 683-95; PMID: 20814421; http://dx.doi.org/10.1038/nrc2899
32. Murtaugh LC Pathogenesis of pancreatic cancer: lessons from animal models. Toxicol Pathol 2014; 42: 217-28; PMID: 24178582; http://dx.doi.org/10.1177/0192623313508250
33. De La O JP, Emerson LL, Goodman JL, Froebe SC, Illum BE, Curtis AB, Murtaugh LC. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 2008; 105: 18907-12; PMID: 19028876; http://dx.doi.org/10.1073/pnas.0810111105
34. Rooman I, Real FX. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? Gut 2012; 61: 449-58; PMID: 21730103; http://dx.doi.org/10.1136/gut.2010.235804
35. Shi C, Hong SM, Lim P, Kamiyama H, Khan M, Anders RA, Goggins M, Hruban RH, Eshleman JR. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Mol Cancer Res 2009; 7: 230-6; PMID: 19208745; http://dx.doi.org/10.1158/1541-7786.MCR-08-0206
36. Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 2007; 171: 263-73; PMID: 17591971; http://dx.doi.org/10.2353/ajpath.2007.061176
37. Ray SK, Nishitani J, Petry MW, Fessing MY, Leiter AB. Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1. Mol Cell Biol 2003; 23: 259-71; PMID: 12482979; http://dx.doi.org/10.1128/MCB.23.1.259-271.2003
38. Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54; PMID: 942051; http://dx.doi.org/10.1016/0003-2697(76)90527-3
39. Desouki MM, Geradts J, Milon B, Franklin RB, Costello LC. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer 2007; 6: 37; PMID: 17550612; http://dx.doi.org/10.1186/1476-4598-6-37